STATCenter·
STAT+: The promise of radiopharmaceuticals smacks into safety concerns
Despite excitement over the potential of radiopharmaceuticals as cancer treatments, drug developers are hitting new hurdles.
Read at STAT →
Health · 1 sources covering this
STAT+: The promise of radiopharmaceuticals smacks into safety concerns
Despite excitement over the potential of radiopharmaceuticals as cancer treatments, drug developers are hitting new hurdles.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/165c7923fc6f7c9f712106064422e91cd5223854" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: The promise of radiopharmaceuticals smacks into safety concerns"></iframe>
